Pricing
Login
Home
Charts
Search
Watchlist
Products

Jubilant Pharmova Ltd

JUBLPHARMA
₹935.05+0.19%20 Nov 2026
Reports
Pharma Formulations

Jubilant Pharmova Ltd

JUBLPHARMA
₹935.05
+0.19%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹14,894Cr
Close
Close Price
₹935.05
Industry
Industry
Pharma Formulations
PE
Price To Earnings
56.29
PS
Price To Sales
1.65
Revenue
Revenue
₹9,012Cr
Rev Gr TTM
Revenue Growth TTM
18.30%
PAT Gr TTM
PAT Growth TTM
-44.67%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,6771,7591,7321,7521,8221,9291,9011,9662,1232,2902,2292,370
Growth YoY
Revenue Growth YoY%
8.04.89.14.38.69.79.812.216.518.717.320.5
Expenses
ExpensesCr
1,4591,4871,4801,4631,5341,5831,6111,6251,8331,9511,9812,130
Operating Profit
Operating ProfitCr
218271252289287345290341290339248241
OPM
OPM%
13.015.414.516.515.817.915.217.413.614.811.110.2
Other Income
Other IncomeCr
49-1514107-109124-19102014
Interest Expense
Interest ExpenseCr
717371615653495056575458
Depreciation
DepreciationCr
951019191919598105121117127135
PBT
PBTCr
101-54500144131206154190931768662
Tax
TaxCr
35818423055527038573031
PAT
PATCr
66-62482103101151103120561195631
Growth YoY
PAT Growth YoY%
512.438.57,930.065.151.7344.8-78.717.0-44.6-21.1-45.0-74.2
NPM
NPM%
4.0-3.527.85.85.57.85.46.12.65.22.51.3
EPS
EPS₹
4.2-3.730.46.56.49.76.57.63.57.53.62.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,6771,7591,7321,7521,8221,9291,9011,9662,1232,2902,2292,370
Growth YoY
Revenue Growth YoY%
8.04.89.14.38.69.79.812.216.518.717.320.5
Expenses
ExpensesCr
1,4591,4871,4801,4631,5341,5831,6111,6251,8331,9511,9812,130
Operating Profit
Operating ProfitCr
218271252289287345290341290339248241
OPM
OPM%
13.015.414.516.515.817.915.217.413.614.811.110.2
Other Income
Other IncomeCr
49-1514107-109124-19102014
Interest Expense
Interest ExpenseCr
717371615653495056575458
Depreciation
DepreciationCr
951019191919598105121117127135
PBT
PBTCr
101-54500144131206154190931768662
Tax
TaxCr
35818423055527038573031
PAT
PATCr
66-62482103101151103120561195631
Growth YoY
PAT Growth YoY%
512.438.57,930.065.151.7344.8-78.717.0-44.6-21.1-45.0-74.2
NPM
NPM%
4.0-3.527.85.85.57.85.46.12.65.22.51.3
EPS
EPS₹
4.2-3.730.46.56.49.76.57.63.57.53.62.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5,7495,8617,5189,1115,9766,0996,1306,2826,7037,2358,2809,012
Growth
Revenue Growth%
-1.31.928.321.2-34.42.00.52.56.77.914.418.3
Expenses
ExpensesCr
4,5024,5165,9997,3724,4284,7024,9745,5065,8026,0617,0207,895
Operating Profit
Operating ProfitCr
1,2471,3451,5181,7391,5481,3961,1567769011,1741,2601,117
OPM
OPM%
21.722.920.219.125.922.918.912.413.416.215.212.4
Other Income
Other IncomeCr
132540-244481-6-76416725
Interest Expense
Interest ExpenseCr
371341284220200184145188272240212225
Depreciation
DepreciationCr
347291415371340349382554382369440500
PBT
PBTCr
5427388599041,01387163028171981614418
Tax
TaxCr
1551632253273352972179398144217155
PAT
PATCr
387575634577678574413-6573836398263
Growth
PAT Growth%
1,063.248.510.4-9.117.5-15.3-28.0-115.7212.01,050.3-52.5-44.7
NPM
NPM%
6.79.88.46.311.39.46.7-1.01.111.64.82.9
EPS
EPS₹
21.832.035.832.048.952.526.0-3.84.953.025.116.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5,7495,8617,5189,1115,9766,0996,1306,2826,7037,2358,2809,012
Growth
Revenue Growth%
-1.31.928.321.2-34.42.00.52.56.77.914.418.3
Expenses
ExpensesCr
4,5024,5165,9997,3724,4284,7024,9745,5065,8026,0617,0207,895
Operating Profit
Operating ProfitCr
1,2471,3451,5181,7391,5481,3961,1567769011,1741,2601,117
OPM
OPM%
21.722.920.219.125.922.918.912.413.416.215.212.4
Other Income
Other IncomeCr
132540-244481-6-76416725
Interest Expense
Interest ExpenseCr
371341284220200184145188272240212225
Depreciation
DepreciationCr
347291415371340349382554382369440500
PBT
PBTCr
5427388599041,01387163028171981614418
Tax
TaxCr
1551632253273352972179398144217155
PAT
PATCr
387575634577678574413-6573836398263
Growth
PAT Growth%
1,063.248.510.4-9.117.5-15.3-28.0-115.7212.01,050.3-52.5-44.7
NPM
NPM%
6.79.88.46.311.39.46.7-1.01.111.64.82.9
EPS
EPS₹
21.832.035.832.048.952.526.0-3.84.953.025.116.6
Sales CAGR
1 Year14%
3 Years10%
5 Years6%
TTM18%
EBITDA CAGR
1 Year7%
3 Years18%
5 Years-2%
TTM-12%
PAT CAGR
1 Year-52%
3 Years-
5 Years-7%
TTM-45%
Avg. ROCE
1 Year8%
3 Years9%
5 Years8%
TTM6%
CFO / EBITDA
1 Year97%
3 Years98%
5 Years91%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616161616161616161616
Reserves
ReservesCr
2,9513,4204,0714,7935,5884,7265,3035,3835,4186,2397,0777,139
Current Liabilities
Current LiabilitiesCr
2,4641,6842,0052,0902,6191,0491,5921,7721,8892,1652,5393,811
Non Current Liabilities
Non Current LiabilitiesCr
3,4323,9683,5784,5704,2993,1283,0833,9934,2384,3535,8885,697
Total Liabilities
Total LiabilitiesCr
8,8249,0419,61811,46912,5228,9189,99111,15711,54912,75615,52316,665
Current Assets
Current AssetsCr
2,8752,9483,1904,5855,0382,9533,5093,7623,8763,5774,1094,281
Non Current Assets
Non Current AssetsCr
5,9496,0936,4286,8847,4835,9666,4827,3947,6729,17911,41312,383
Total Assets
Total AssetsCr
8,8249,0419,61811,46912,5228,9189,99111,15711,54912,75615,52316,665
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616161616161616161616
Reserves
ReservesCr
2,9513,4204,0714,7935,5884,7265,3035,3835,4186,2397,0777,139
Current Liabilities
Current LiabilitiesCr
2,4641,6842,0052,0902,6191,0491,5921,7721,8892,1652,5393,811
Non Current Liabilities
Non Current LiabilitiesCr
3,4323,9683,5784,5704,2993,1283,0833,9934,2384,3535,8885,697
Total Liabilities
Total LiabilitiesCr
8,8249,0419,61811,46912,5228,9189,99111,15711,54912,75615,52316,665
Current Assets
Current AssetsCr
2,8752,9483,1904,5855,0382,9533,5093,7623,8763,5774,1094,281
Non Current Assets
Non Current AssetsCr
5,9496,0936,4286,8847,4835,9666,4827,3947,6729,17911,41312,383
Total Assets
Total AssetsCr
8,8249,0419,61811,46912,5228,9189,99111,15711,54912,75615,52316,665

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0991,2681,3031,1221,5431,7848386619711,0721,227
Investing Cash Flow
Investing Cash FlowCr
-313-450-618-1,012-327-739-380-544-608488-1,260
Financing Cash Flow
Financing Cash FlowCr
-843-686-901657-1,050-1,709-33-157-433-1,45395
Net Cash Flow
Net Cash FlowCr
-52117-212761225-65248230-58132179
Free Cash Flow
Free Cash FlowCr
7608068194739751,270241-13583-39-120
CFO To PAT
CFO To PAT%
284.1220.8205.4194.4227.7310.9202.8-1,018.01,336.0128.2308.6
CFO To EBITDA
CFO To EBITDA%
88.194.385.864.599.7127.872.485.1107.891.397.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0991,2681,3031,1221,5431,7848386619711,0721,227
Investing Cash Flow
Investing Cash FlowCr
-313-450-618-1,012-327-739-380-544-608488-1,260
Financing Cash Flow
Financing Cash FlowCr
-843-686-901657-1,050-1,709-33-157-433-1,45395
Net Cash Flow
Net Cash FlowCr
-52117-212761225-65248230-58132179
Free Cash Flow
Free Cash FlowCr
7608068194739751,270241-13583-39-120
CFO To PAT
CFO To PAT%
284.1220.8205.4194.4227.7310.9202.8-1,018.01,336.0128.2308.6
CFO To EBITDA
CFO To EBITDA%
88.194.385.864.599.7127.872.485.1107.891.397.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6,63212,71913,37810,5813,96410,8396,1784,4459,05614,22113,00614,894
Price To Earnings
Price To Earnings
16.521.620.418.44.413.014.9116.516.832.456.3
Price To Sales
Price To Sales
1.12.21.81.20.71.81.00.71.42.01.61.6
Price To Book
Price To Book
2.23.63.22.20.72.31.20.81.62.31.82.1
EV To EBITDA
EV To EBITDA
8.111.910.88.04.69.37.39.213.113.512.216.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.352.949.950.267.965.864.558.458.358.558.558.5
OPM
OPM%
21.722.920.219.125.922.918.912.413.416.215.212.4
NPM
NPM%
6.79.88.46.311.39.46.7-1.01.111.64.82.9
ROCE
ROCE%
13.615.015.511.811.913.99.12.44.913.67.75.8
ROE
ROE%
13.016.715.512.012.112.17.8-1.21.313.45.63.7
ROA
ROA%
4.46.46.65.05.46.44.1-0.60.66.62.61.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6,63212,71913,37810,5813,96410,8396,1784,4459,05614,22113,00614,894
Price To Earnings
Price To Earnings
16.521.620.418.44.413.014.9116.516.832.456.3
Price To Sales
Price To Sales
1.12.21.81.20.71.81.00.71.42.01.61.6
Price To Book
Price To Book
2.23.63.22.20.72.31.20.81.62.31.82.1
EV To EBITDA
EV To EBITDA
8.111.910.88.04.69.37.39.213.113.512.216.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.352.949.950.267.965.864.558.458.358.558.558.5
OPM
OPM%
21.722.920.219.125.922.918.912.413.416.215.212.4
NPM
NPM%
6.79.88.46.311.39.46.7-1.01.111.64.82.9
ROCE
ROCE%
13.615.015.511.811.913.99.12.44.913.67.75.8
ROE
ROE%
13.016.715.512.012.112.17.8-1.21.313.45.63.7
ROA
ROA%
4.46.46.65.05.46.44.1-0.60.66.62.61.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr18,27515,97415,42414,89413,84213,19610,958
Close PriceClose₹1,317.20814.302,029.10935.052,263.20291.15696.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.6017.7422.3856.2966.8623.5629.30
Price To SalesPS5.495.176.471.658.883.892.27
RevenueRevenueCr3,3303,0892,3839,0121,5593,3924,826
Revenue Growth TTMRev Gr TTM%11.1%-29.6%16.8%18.3%20.0%24.2%17.5%
PAT Growth TTMPAT Gr TTM%60.0%-56.4%17.4%-44.7%18.3%60.2%12.8%
Market CapitalizationMkt CapCr18,27515,97415,42414,89413,84213,19610,958
Close PriceClose₹1,317.20814.302,029.10935.052,263.20291.15696.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.6017.7422.3856.2966.8623.5629.30
Price To SalesPS5.495.176.471.658.883.892.27
RevenueRevenueCr3,3303,0892,3839,0121,5593,3924,826
Revenue Growth TTMRev Gr TTM%11.1%-29.6%16.8%18.3%20.0%24.2%17.5%
PAT Growth TTMPAT Gr TTM%60.0%-56.4%17.4%-44.7%18.3%60.2%12.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 26
ResultPPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Sep 22
Mar 22
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 26
ResultPPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Sep 22
Mar 22
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews